DNA Array-Based Gene Profiling in Tumor Immunology

Recent advances in tumor immunology have fostered the clinical implementation of different immunotherapy modalities. However, the alternate success of such regimens underscores the fact that the molecular mechanisms underlying tumor immune rejection are still poorly understood. Given the complexity of the immune system network and the multidimensionality of tumor–host interactions, the comprehension of tumor immunology might greatly benefit from high-throughput DNA array analysis, which can portray the molecular kinetics of immune response on a genome-wide scale, thus accelerating the accumulation of knowledge and ultimately catalyzing the development of new hypotheses in cell biology. Although in its infancy, the implementation of DNA array technology in tumor immunology studies has already provided investigators with novel data and intriguing hypotheses on the cascade of molecular events leading to an effective immune response against cancer. Although the principles of DNA array-based gene profiling techniques have become common knowledge, the need for mastering this technique to produce meaningful data and correctly interpret this enormous output of information is critical and represents a tremendous challenge for investigators. In the present work, we summarize the main technical features and critical issues characterizing this powerful laboratory tool and review its applications in the fascinating field of cancer immunogenomics.

[1]  F. Marincola,et al.  The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle. , 2004, Cytokine & growth factor reviews.

[2]  F. Marincola,et al.  Dissecting tumor responsiveness to immunotherapy: the experience of peptide-based melanoma vaccines. , 2003, Biochimica et biophysica acta.

[3]  K. Elenitoba-Johnson,et al.  Validation of cDNA microarray gene expression data obtained from linearly amplified RNA , 2003, Molecular pathology : MP.

[4]  J. Ioannidis,et al.  Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment , 2003, The Lancet.

[5]  Soldano Ferrone,et al.  Tumors as elusive targets of T-cell-based active immunotherapy. , 2003, Trends in immunology.

[6]  F. Marincola,et al.  Quantitative real-time PCR: a powerful ally in cancer research. , 2003, Trends in molecular medicine.

[7]  G. Parmiani,et al.  Suboptimal activation of CD8(+) T cells by melanoma-derived altered peptide ligands: role of Melan-A/MART-1 optimized analogues. , 2003, Cancer research.

[8]  May D. Wang,et al.  GoMiner: a resource for biological interpretation of genomic and proteomic data , 2003, Genome Biology.

[9]  S. Reed,et al.  L523S, an RNA-binding protein as a potential therapeutic target for lung cancer , 2003, British Journal of Cancer.

[10]  T. Whiteside,et al.  Enzyme-linked immunospot, cytokine flow cytometry, and tetramers in the detection of T-cell responses to a dendritic cell-based multipeptide vaccine in patients with melanoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  Jun Luo,et al.  Looking Beyond Morphology: Cancer Gene Expression Profiling Using DNA Microarrays , 2003, Cancer investigation.

[12]  D. Slonim From patterns to pathways: gene expression data analysis comes of age , 2002, Nature Genetics.

[13]  G. Churchill Fundamentals of experimental design for cDNA microarrays , 2002, Nature Genetics.

[14]  Yusuke Nakamura,et al.  Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. , 2002, Cancer research.

[15]  C. Nguyen,et al.  Gene Profiling Approach to Establish the Molecular Bases for Partial versus Full Activation of Naïve CD8 T Lymphocytes , 2002, Annals of the New York Academy of Sciences.

[16]  J. Xiang,et al.  DNA microarray analysis of the gene expression profiles of naïve versus activated tumor-specific T cells. , 2002, Life sciences.

[17]  Hans-Georg Rammensee,et al.  Integrated functional genomics approach for the design of patient-individual antitumor vaccines. , 2002, Cancer research.

[18]  S K Libutti,et al.  Advantages of mRNA amplification for microarray analysis. , 2002, BioTechniques.

[19]  M. Raffeld,et al.  Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.

[20]  Yingdong Zhao,et al.  Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. , 2002, Cancer research.

[21]  F. Marincola,et al.  Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration , 2002, Genome Biology.

[22]  Yuyu Kuang,et al.  Conserved codon composition of ribosomal protein coding genes in Escherichia coli, Mycobacterium tuberculosis and Saccharomyces cerevisiae: lessons from supervised machine learning in functional genomics. , 2002, Nucleic acids research.

[23]  G. Schuler,et al.  Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic Cells , 2002, The Journal of experimental medicine.

[24]  N. Broude Differential display in the time of microarrays , 2002, Expert review of molecular diagnostics.

[25]  U. Scherf,et al.  Large-scale gene expression analysis in molecular target discovery , 2002, Leukemia.

[26]  J. Xiang,et al.  Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression. , 2002, Cancer research.

[27]  Drew M. Pardoll,et al.  Vaccines: Spinning molecular immunology into successful immunotherapy , 2002, Nature Reviews Immunology.

[28]  M. Atkins,et al.  Immunologic Monitoring of Cancer Vaccine Therapy: Results of a Workshop Sponsored by the Society for Biological Therapy , 2002, Journal of immunotherapy.

[29]  Ji Huang,et al.  [Serial analysis of gene expression]. , 2002, Yi chuan = Hereditas.

[30]  J. Xiang,et al.  Analysis of the gene expression profiles of immature versus mature bone marrow-derived dendritic cells using DNA arrays. , 2002, Biochemical and biophysical research communications.

[31]  J. Gordon,et al.  DNA array and biological characterization of the impact of the maturation status of mouse dendritic cells on their phenotype and antitumor vaccination efficacy. , 2001, Cellular immunology.

[32]  S. Reed,et al.  L552S, an alternatively spliced isoform of XAGE-1, is over-expressed in lung adenocarcinoma , 2001, Oncogene.

[33]  K R Hess,et al.  Microarrays: handling the deluge of data and extracting reliable information. , 2001, Trends in biotechnology.

[34]  K. Anderson,et al.  Linking genomics to immunotherapy by reverse immunology--'immunomics' in the new millennium. , 2001, Current molecular medicine.

[35]  A. Giuliani,et al.  The main biological determinants of tumor line taxonomy elucidated by a principal component analysis of microarray data , 2001, FEBS letters.

[36]  R. Ciubotariu,et al.  Distinct mRNA microarray profiles of tolerogenic dendritic cells. , 2001, Human immunology.

[37]  F. Marincola,et al.  Cytokines and Immune Response in the Tumor Microenvironment , 2001, Journal of immunotherapy.

[38]  R. Steinman,et al.  Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. , 2001, Cancer research.

[39]  Antonio Lanzavecchia,et al.  Regulation of T Cell Immunity by Dendritic Cells , 2001, Cell.

[40]  K. Furge,et al.  Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. Brazma,et al.  Gene expression data analysis. , 2001, FEBS letters.

[42]  F. Marincola,et al.  Kinetics of cytokine expression in melanoma metastases classifies immune responsiveness , 2001, International journal of cancer.

[43]  C. Akdis,et al.  Mechanisms of interleukin‐10‐mediated immune suppression , 2001, Immunology.

[44]  M. Ringnér,et al.  Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks , 2001, Nature Medicine.

[45]  Steven A. Rosenberg,et al.  Progress in human tumour immunology and immunotherapy , 2001, Nature.

[46]  J. Dopazo,et al.  Methods and approaches in the analysis of gene expression data. , 2001, Journal of immunological methods.

[47]  Yudong D. He,et al.  Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer , 2001, Nature Biotechnology.

[48]  Søren Buus,et al.  Tumor‐associated antigens identified by mRNA expression profiling induce protective anti‐tumor immunity , 2001, European journal of immunology.

[49]  O. Kallioniemi,et al.  Tissue microarray technology for high-throughput molecular profiling of cancer. , 2001, Human molecular genetics.

[50]  M. Mayford,et al.  A GFP-equipped bidirectional expression module well suited for monitoring tetracycline-regulated gene expression in mouse. , 2001, Nucleic acids research.

[51]  E. Brown,et al.  Quantitative analysis of mRNA amplification by in vitro transcription. , 2001, Nucleic acids research.

[52]  F. Marincola,et al.  A natural history of melanoma: serial gene expression analysis. , 2000, Immunology today.

[53]  Jiasen Lu,et al.  Assessment of the sensitivity and specificity of oligonucleotide (50mer) microarrays. , 2000, Nucleic acids research.

[54]  G. A. Whitmore,et al.  Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[56]  F. Marincola,et al.  Phase 1 Study in Patients With Metastatic Melanoma of Immunization With Dendritic Cells Presenting Epitopes Derived From the Melanoma-Associated Antigens MART-1 and gp100 , 2000, Journal of immunotherapy.

[57]  A. Toulouse,et al.  RARβ involvement in enhancement of lung tumor cell immunogenicity revealed by array analysis , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  G. Sherlock Analysis of large-scale gene expression data. , 2000, Current opinion in immunology.

[59]  K. Margolin Interleukin-2 in the treatment of renal cancer. , 2000, Seminars in oncology.

[60]  F. Marincola,et al.  High-fidelity mRNA amplification for gene profiling , 2000, Nature Biotechnology.

[61]  M Roederer,et al.  Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[62]  Christian A. Rees,et al.  Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.

[63]  T. Hughes,et al.  Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles. , 2000, Science.

[64]  S. Lederman,et al.  T Suppressor Lymphocytes Inhibit NF-κB-Mediated Transcription of CD86 Gene in APC , 1999, The Journal of Immunology.

[65]  A. Enk,et al.  Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma , 1999, The Journal of experimental medicine.

[66]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[67]  F. Bertucci,et al.  Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples. , 1999, Human molecular genetics.

[68]  R. Fisher,et al.  High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[69]  S. Lederman,et al.  Inhibition of CD40 signaling pathway in antigen presenting cells by T suppressor cells. , 1999, Human immunology.

[70]  P. Törönen,et al.  Analysis of gene expression data using self‐organizing maps , 1999, FEBS letters.

[71]  D. Morton,et al.  Active specific immunotherapy with polyvalent melanoma cell vaccine for patients with in‐transit melanoma metastases , 1999, Cancer.

[72]  Goldenfeld,et al.  Simple lessons from complexity , 1999, Science.

[73]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[74]  G. Pennesi,et al.  Specific suppression of human CD4+ Th cell responses to pig MHC antigens by CD8+CD28- regulatory T cells. , 1998, Journal of immunology.

[75]  W. Kuo,et al.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays , 1998, Nature Genetics.

[76]  A. Lanzavecchia Licence to kill , 1998 .

[77]  Zhuoru Liu,et al.  Specific suppression of T helper alloreactivity by allo-MHC class I-restricted CD8+CD28- T cells. , 1998, International immunology.

[78]  F. Marincola,et al.  Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma , 1998, Nature Medicine.

[79]  Dirk Schadendorf,et al.  Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells , 1998, Nature Medicine.

[80]  P. Nurse,et al.  Reductionism: The ends of understanding , 1997, Nature.

[81]  P. Walker,et al.  Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back. , 1997, Journal of immunology.

[82]  E. Petricoin,et al.  Laser Capture Microdissection , 1996, Science.

[83]  Philip J. R. Goulder,et al.  Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.

[84]  Ronald W. Davis,et al.  Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.

[85]  R. Henderson,et al.  Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. , 1994, Science.

[86]  P. Singer Licence to kill , 1994, Nature.

[87]  P. Chomez,et al.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. , 1991, Science.

[88]  S. Rosenberg,et al.  Induction of endogenous cytokine-mRNA in circulating peripheral blood mononuclear cells by IL-2 administration to cancer patients. , 1989, Journal of immunology.

[89]  S. Rosenberg,et al.  Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome. , 1988, Journal of immunology.

[90]  F. Marincola,et al.  The dual role of IL-10. , 2003, Trends in immunology.

[91]  M. Smyth,et al.  Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection , 2002, Nature Immunology.

[92]  M Vingron,et al.  Identification and Classification of Differentially Expressed Genes in Renal Cell Carcinoma by Expression Profiling on a Global Human 31 , 500-Element cDNA Array , 2001 .

[93]  Andreas D. Baxevanis,et al.  The Molecular Biology Database Collection: an updated compilation of biological database resources , 2001, Nucleic Acids Res..

[94]  F. Le Naour Contribution of proteomics to tumor immunology. , 2001, Proteomics.

[95]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.

[96]  F. Marincola,et al.  Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. , 2000, Advances in immunology.

[97]  D. Botstein,et al.  The transcriptional program in the response of human fibroblasts to serum. , 1999, Science.

[98]  D. Botstein,et al.  Exploring the new world of the genome with DNA microarrays , 1999, Nature Genetics.

[99]  S. Lederman,et al.  T suppressor lymphocytes inhibit NF-kappa B-mediated transcription of CD86 gene in APC. , 1999, Journal of immunology.

[100]  S. Rosenberg,et al.  Human melanoma cells do not express Fas (Apo-1/CD95) ligand. , 1999, Cancer research.

[101]  D. Lockhart,et al.  Expression monitoring by hybridization to high-density oligonucleotide arrays , 1996, Nature Biotechnology.

[102]  P. Anderson TIA-1: structural and functional studies on a new class of cytolytic effector molecule. , 1995, Current topics in microbiology and immunology.

[103]  D. Pardoll Paracrine cytokine adjuvants in cancer immunotherapy. , 1995, Annual review of immunology.

[104]  P. Matzinger Tolerance, danger, and the extended family. , 1994, Annual review of immunology.

[105]  O RAJKA,et al.  [TUMOR IMMUNOLOGY]. , 1963, Orvosi hetilap.